Collaboration Agreement Sartorius Stedim Biotech and Novasep to Develop Novel Systems for Membrane Chromatography
Sartorius Stedim Biotech (SSB) and Novasep have recently entered into a collaboration agreement in the area of chromatography and single-use bioprocessing.
Novasep provides various products and services to the life science industry, based on specialised technologies. In particular, this company is a recognised system provider with substantial expertise in the design, manufacture and control of resin-based batch and continuous chromatography systems.
Novasep’s established Bio SC platform and SSB’s single use technology will form the basis for the development of innovative chromatography systems. Systems currently in the market are designed for resins, but do not take full advantage of membrane chromatography capabilities, states Sartorius Stedim Biotech.
Optimally run membrane chromatography processes will provide the most attractive alternative to batch and continuous resin-based chromatography - namely higher productivity, smaller scale operations and increased robustness.
Systems designed for membrane chromatography applications are a part of SSB’s global product strategy to supply complete solutions for upstream and downstream processing in life sciences.
This collaboration is a wonderful opportunity for Novasep and Sartorius Stedim Biotech, as it leverages the core capabilities of the two companies. The result of this venture will satisfy the latest market demands for continuous processing, process intensification, performance, and ease of use, mentions Novasep.